跳至主要内容
临床试验/NL-OMON44121
NL-OMON44121已完成不适用

Biological variation of cardiac biomarkers in aortic valve stenosis - Biological variation of cardiac biomarkers in aortic valve stenosis

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Individuals (aged * 18 years) with clinically stable moderate aortic valve stenosis, defined by serial Doppler echocardiographic measurements of maximum transvalvular velocity (Vmax), mean pressure gradient (PGmean), and Aortic Valve Area (AVA) and a preserved ejection fraction (EF), will be recruited to participate in this study. Only subjects who are able to provide informed consent will be included.

排除标准

  • Subjects with severe aortic valve stenosis
  • Subjects with clinically progressive aortic valve stenosis
  • Subjects with documented atrial fibrillation in the last year. (subjects are allowed to have a history of atrial fibrillation)
  • Subjects with acute myocardial infarction in the last 6 months
  • Subjects with hospitalisation for heart failure in the last 6 months
  • Subjects with pulmonary embolism in the last 6 months
  • Subjects with chronic kidney disease (CKD)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验